Home

Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revisionPrevious revision
Last revisionBoth sides next revision
home:starting:safety_warnings [10.19.2018] – [Immunopathology is dangerous and may be difficult to control] sallieqhome:starting:safety_warnings [10.19.2018] – [Notes and comments] sallieq
Line 87: Line 87:
  
   * Updated wording, but still think it could be made even better with more work. --Joyful May'13   * Updated wording, but still think it could be made even better with more work. --Joyful May'13
-  * added "Xarelto increases the risk of bleeding and can cause serious or fatal bleeding. A specific antidote for rivaroxaban is not available. Because of high plasma protein binding, rivaroxaban is not expected to be dialyzable." --Sallie Q May15  
-  * altered 3rd line to 'sufficient olmesartan medoxomil (Benicar) to ensure that patient does not run out if there is a delay in delivery or in renewing prescription' --- //Sallie Q 11.02.2016// 
  
-alteration ( @ Patients must understand..) why the use of  telmisartan or azithromycin is considered particularly dangerous  --- //Sallie Q 09.15.2017//+ 
home/starting/safety_warnings.txt · Last modified: 09.14.2022 by 127.0.0.1
© 2015, Autoimmunity Research Foundation. All Rights Reserved.